1. Home
  2. ACXP vs MEGL Comparison

ACXP vs MEGL Comparison

Compare ACXP & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • MEGL
  • Stock Information
  • Founded
  • ACXP 2017
  • MEGL 2016
  • Country
  • ACXP United States
  • MEGL Hong Kong
  • Employees
  • ACXP N/A
  • MEGL N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • MEGL Finance: Consumer Services
  • Sector
  • ACXP Health Care
  • MEGL Finance
  • Exchange
  • ACXP Nasdaq
  • MEGL Nasdaq
  • Market Cap
  • ACXP 6.8M
  • MEGL 6.8M
  • IPO Year
  • ACXP 2021
  • MEGL 2022
  • Fundamental
  • Price
  • ACXP $4.45
  • MEGL $1.19
  • Analyst Decision
  • ACXP Strong Buy
  • MEGL
  • Analyst Count
  • ACXP 3
  • MEGL 0
  • Target Price
  • ACXP $143.67
  • MEGL N/A
  • AVG Volume (30 Days)
  • ACXP 75.7K
  • MEGL 42.5K
  • Earning Date
  • ACXP 11-12-2025
  • MEGL 12-11-2025
  • Dividend Yield
  • ACXP N/A
  • MEGL N/A
  • EPS Growth
  • ACXP N/A
  • MEGL N/A
  • EPS
  • ACXP N/A
  • MEGL N/A
  • Revenue
  • ACXP N/A
  • MEGL $1,296,394.00
  • Revenue This Year
  • ACXP N/A
  • MEGL N/A
  • Revenue Next Year
  • ACXP N/A
  • MEGL N/A
  • P/E Ratio
  • ACXP N/A
  • MEGL N/A
  • Revenue Growth
  • ACXP N/A
  • MEGL N/A
  • 52 Week Low
  • ACXP $3.80
  • MEGL $1.02
  • 52 Week High
  • ACXP $29.40
  • MEGL $5.52
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 41.55
  • MEGL 37.78
  • Support Level
  • ACXP $4.51
  • MEGL $1.18
  • Resistance Level
  • ACXP $5.79
  • MEGL $1.38
  • Average True Range (ATR)
  • ACXP 0.44
  • MEGL 0.07
  • MACD
  • ACXP -0.09
  • MEGL -0.01
  • Stochastic Oscillator
  • ACXP 24.34
  • MEGL 18.18

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: